Axcella Health Performance
| AXLADelisted Stock | USD 0.20 0.02 11.11% |
The firm shows a Beta (market volatility) of -0.0128, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Axcella Health are expected to decrease at a much lower rate. During the bear market, Axcella Health is likely to outperform the market. Axcella Health right now shows a risk of 0.0%. Please confirm Axcella Health coefficient of variation, value at risk, rate of daily change, as well as the relationship between the total risk alpha and kurtosis , to decide if Axcella Health will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Axcella Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Axcella Health is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 23.6 M | |
| Free Cash Flow | -70 M |
Axcella |
Axcella Health Relative Risk vs. Return Landscape
If you would invest 20.00 in Axcella Health on September 5, 2024 and sell it today you would earn a total of 0.00 from holding Axcella Health or generate 0.0% return on investment over 90 days. Axcella Health is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Axcella, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Axcella Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Axcella Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Axcella Health, and traders can use it to determine the average amount a Axcella Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AXLA |
Based on monthly moving average Axcella Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Axcella Health by adding Axcella Health to a well-diversified portfolio.
Axcella Health Fundamentals Growth
Axcella Stock prices reflect investors' perceptions of the future prospects and financial health of Axcella Health, and Axcella Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Axcella Stock performance.
| Return On Equity | -13.7 | |||
| Return On Asset | -0.88 | |||
| Current Valuation | 1.94 M | |||
| Shares Outstanding | 2.95 M | |||
| Price To Earning | (1.10) X | |||
| Price To Book | 8.74 X | |||
| EBITDA | (67.01 M) | |||
| Cash And Equivalents | 44.4 M | |||
| Cash Per Share | 0.84 X | |||
| Total Debt | 2.16 M | |||
| Debt To Equity | 3.02 % | |||
| Book Value Per Share | (0.77) X | |||
| Cash Flow From Operations | (69.59 M) | |||
| Earnings Per Share | (18.25) X | |||
| Total Asset | 18.93 M | |||
| Retained Earnings | (418.43 M) | |||
| Current Asset | 61.65 M | |||
| Current Liabilities | 6.16 M | |||
About Axcella Health Performance
By analyzing Axcella Health's fundamental ratios, stakeholders can gain valuable insights into Axcella Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Axcella Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Axcella Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts. Axcella Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.Things to note about Axcella Health performance evaluation
Checking the ongoing alerts about Axcella Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Axcella Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Axcella Health is not yet fully synchronised with the market data | |
| Axcella Health has some characteristics of a very speculative penny stock | |
| Axcella Health has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (81.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Axcella Health currently holds about 44.4 M in cash with (69.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.84, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 67.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Axcella Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Axcella Health's stock is overvalued or undervalued compared to its peers.
- Examining Axcella Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Axcella Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Axcella Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Axcella Health's stock. These opinions can provide insight into Axcella Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Axcella Stock
If you are still planning to invest in Axcella Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axcella Health's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |